StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-0.08%)

Close on Nov 18, 2026Market cap $383.32KP/E –Yield –

VivoSim Labs revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

VivoSim Labs's revenue for the twelve months ending Jun 30, 2026 was $112.00K, down 21.1% year over year. For fiscal 2026 it was $131.00K, down 9.0% from the year before. Over ten years it grew -21.5% a year on average. The highest annual figure on record is $4.60M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2026Mar 31, 2026$131.00K-9.0%
FY2025Mar 31, 2025$144.00K+32.1%
FY2024Mar 31, 2024$109.00K-70.5%
FY2023Mar 31, 2023$370.00K-75.3%
FY2022Mar 31, 2022$1.50M–
FY2021Mar 31, 2021$0-100.0%
FY2020Mar 31, 2020$2.20M-29.0%
FY2019Mar 31, 2019$3.09M-32.8%
FY2018Mar 31, 2018$4.60M+8.8%
FY2017Mar 31, 2017$4.23M+185.2%
FY2016Mar 31, 2016$1.48M+159.7%
FY2015Mar 31, 2015$571.00K-52.3%
FY2012Dec 31, 2012$1.20M+23.5%
FY2011Dec 31, 2011$969.00K+60.7%
FY2010Dec 31, 2010$603.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$18.00K-51.4%
Q4 FY2026CQ1 2026Mar 31, 2026$40.00K-21.6%
Q3 FY2026CQ4 2025Dec 31, 2025$26.00K+8.3%
Q2 FY2026CQ3 2025Sep 30, 2025$28.00K-6.7%
Q1 FY2026CQ2 2025Jun 30, 2025$37.00K-5.1%
Q4 FY2025CQ1 2025Mar 31, 2025$51.00K+75.9%
Q3 FY2025CQ4 2024Dec 31, 2024$24.00K+380.0%
Q2 FY2025CQ3 2024Sep 30, 2024$30.00K–
Q1 FY2025CQ2 2024Jun 30, 2024$39.00K-48.0%
Q4 FY2024CQ1 2024Mar 31, 2024$29.00K-82.1%
Q3 FY2024CQ4 2023Dec 31, 2023$5.00K-96.2%
Q2 FY2024CQ3 2023Sep 30, 2023$0-100.0%
Q1 FY2024CQ2 2023Jun 30, 2023$75.00K–
Q4 FY2023CQ1 2023Mar 31, 2023$162.00K-89.2%
Q3 FY2023CQ4 2022Dec 31, 2022$131.00K–
Q2 FY2023CQ3 2022Sep 30, 2022$77.00K–
Q1 FY2023CQ2 2022Jun 30, 2022$0–
Q4 FY2022CQ1 2022Mar 31, 2022$1.50M–
Q3 FY2022CQ4 2021Dec 31, 2021$0–
Q2 FY2022CQ3 2021Sep 30, 2021$0–
Q4 FY2021CQ1 2021Mar 31, 2021$0–
Q3 FY2021CQ4 2020Dec 31, 2020$0-100.0%
Q2 FY2021CQ3 2020Sep 30, 2020$0-100.0%
Q1 FY2021CQ2 2020Jun 30, 2020$0-100.0%
Q4 FY2020CQ1 2020Mar 31, 2020$0-100.0%
Q3 FY2020CQ4 2019Dec 31, 2019$298.00K-61.7%
Q2 FY2020CQ3 2019Sep 30, 2019$1.23M+30.4%
Q1 FY2020CQ2 2019Jun 30, 2019$668.00K-3.0%
Q4 FY2019CQ1 2019Mar 31, 2019$680.00K-38.5%
Q3 FY2019CQ4 2018Dec 31, 2018$779.00K-32.4%
Q2 FY2019CQ3 2018Sep 30, 2018$943.00K-30.4%
Q1 FY2019CQ2 2018Jun 30, 2018$689.00K-30.4%
Q4 FY2018CQ1 2018Mar 31, 2018$1.11M+36.1%
Q3 FY2018CQ4 2017Dec 31, 2017$1.15M+0.2%
Q2 FY2018CQ3 2017Sep 30, 2017$1.36M-1.5%
Q1 FY2018CQ2 2017Jun 30, 2017$990.00K–
Q4 FY2017CQ1 2017Mar 31, 2017$812.00K–
Q3 FY2017CQ4 2016Dec 31, 2016$1.15M–
Q2 FY2017CQ3 2016Sep 30, 2016$1.38M–

More VivoSim Labs figures

See a number that looks wrong?